- Home
- CPT vs RGC Comparison
CPT vs RGC Comparison
Compare CPT & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CPT | RGC |
|---|---|---|
| Founded | 1993 | 2014 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medicinal Chemicals and Botanical Products |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.8B | 11.5B |
| IPO Year | 1995 | 2020 |
Fundamental Metrics
Financial Performance| Metric | CPT | RGC |
|---|---|---|
| Price | $112.97 | $5.92 |
| Analyst Decision | Buy | |
| Analyst Count | 17 | 0 |
| Target Price | ★ $115.28 | N/A |
| AVG Volume (30 Days) | ★ 976.7K | 524.0K |
| Earning Date | 04-30-2026 | 10-31-2025 |
| Dividend Yield | ★ 4.03% | N/A |
| EPS Growth | ★ 136.00 | N/A |
| EPS | ★ 0.40 | N/A |
| Revenue | ★ $12,967,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.60 | N/A |
| P/E Ratio | $283.25 | ★ N/A |
| Revenue Growth | ★ 81.69 | N/A |
| 52 Week Low | $96.53 | $5.17 |
| 52 Week High | $119.81 | $69.00 |
Technical Indicators
Market Signals| Indicator | CPT | RGC |
|---|---|---|
| Relative Strength Index (RSI) | 50.62 | 24.34 |
| Support Level | $105.41 | N/A |
| Resistance Level | $116.59 | $25.78 |
| Average True Range (ATR) | 1.95 | 1.72 |
| MACD | -0.36 | 0.20 |
| Stochastic Oscillator | 41.99 | 7.64 |
Price Performance
Historical ComparisonAbout CPT Camden Property Trust
Camden Property Trust is a real estate investment trust engaged in the ownership, management, development, reposition, redevelopment, acquisition, and construction of multifamily apartment communities. It owned interests in, operated, or developing nearly 175 multifamily properties comprised of nearly 59,921 apartment homes across the United States.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.